Sickle Cell Disease Treatment In Bahrain
Pediatric
Sickle cell disease is a lifelong genetic blood disorder that affects how red blood cells transport oxygen throughout the body. Over time, these cells can become rigid and irregular in shape, making it difficult for them to pass smoothly through blood vessels and deliver oxygen efficiently.
As a result, blood flow may become partially blocked, triggering painful episodes and straining important organs such as the brain, lungs, kidneys, and the immune system. Without consistent and timely medical care, individuals may develop complications such as infections, organ damage, and a decline in overall health.
At King’s College Hospital London – Dubai, Bahrain Clinic, care is guided by international standards and decades of clinical experience. With a strong emphasis on early diagnosis and continuous support, patients seeking sickle cell disease treatment in Bahrain receive a well-rounded, multidisciplinary approach aimed at improving long-term health outcomes.
Understanding Sickle Cell disease
Sickle cell disease is not a single condition but a group of inherited disorders that affect red blood cells.
In a healthy body, red blood cells are flexible and round, moving easily through blood vessels to deliver oxygen. However, in people with sickle cell anemia, a genetic change affects hemoglobin, the protein that carries oxygen, to form into stiff, “sickle” or crescent shapes.
These rigid cells can become stuck in small blood vessels, obstructing blood flow. This leads to periodic episodes of pain (crises) and can cause serious damage to organs over time.
Types of Sickle Cell disease
- HbSS disease (Sickle cell anemia): The most common and severe form, where a child inherits two sickle cell genes. It is associated with frequent pain episodes, anemia, and a higher risk of complications.
- HbSC disease: A milder but still significant form. One sickle cell gene is inherited along with one hemoglobin C gene, with variable symptoms and complications.
- Sickle beta-thalassemia: Occurs when one sickle cell gene is inherited along with a beta-thalassemia gene. The severity depends on the specific form of thalassemia present, ranging from mild to severe.
What causes Sickle Cell disease?
Sickle cell disease happens due to a genetic mutation in the gene that produces hemoglobin,the protein in red blood cells responsible for carrying oxygen throughout the body. This change results in abnormal hemoglobin, which alters the shape and flexibility of red blood cells, making them rigid and sickle-shaped.
Sickle cell disease follows an autosomal recessive inheritance pattern. This means a child must inherit one defective gene from each parent to develop sickle cell disease.
If both parents are carriers, there is
- A 25% chance the child will have sickle cell disease
- A 50% chance the child will be a carrier
- A 25% chance the child will not inherit the gene
Because it is a genetic condition, sickle cell disease is present from birth, although symptoms may not appear until early infancy.
Recognizing the signs: Symptoms of Sickle Cell disease
Symptoms don’t look the same for everyone and can change as time goes on. Some people may only notice mild discomfort, while others go through repeated or more serious complications that need regular medical attention.
Common signs include:
- Pain crises: Sudden and often intense pain caused by blocked blood flow, typically affecting bones, chest, abdomen, or joints.
- Swelling in hands and feet: Often one of the earliest signs in infants due to poor circulation.
- Chronic fatigue: Due to ongoing anemia and reduced oxygen delivery.
- Frequent infections: Especially in children, as the immune system may be weakened.
- Jaundice: Yellowing of the skin and eyes resulting from the breakdown of red blood cells
- Delayed growth and puberty: Resulting from reduced oxygen supply to tissues.
- Shortness of breath or chest pain: May be a sign of lung-related complications.
Recognizing these symptoms early makes a significant difference by enabling prompt treatment and more effective management of sickle cell disease, which can help prevent complications and enhance overall quality of life.
Complications caused by Sickle Cell Anemia
If not properly managed, sickle cell disease can lead to serious complications such as:
- Stroke and silent cerebral infarcts
- Acute chest syndrome (a life-threatening lung complication)
- Organ damage (kidney, liver, spleen)
- Pulmonary hypertension
- Severe infections due to weakened immunity
Securing a diagnosis of Sickle Cell disease
Accurate and timely diagnosis of sickle cell disease is essential for initiating early care and preventing complications. In many cases, the condition is identified in infancy through routine newborn screening, but it can also be diagnosed later based on symptoms or family history.
Diagnostic tests may include:
- Hemoglobin electrophoresis: The gold standard test used to identify abnormal hemoglobin types.
- Peripheral blood smear: Allows visualization of abnormally shaped red blood cells.
- High-Performance Liquid Chromatography (HPLC): A precise method to confirm and quantify different hemoglobin variants.
- Complete Blood Count (CBC): Helps detect anemia and assess overall red blood cell health.
- Genetic testing: May be advised to confirm the diagnosis or for family planning purposes.
Ongoing follow-up is essential after diagnosis to monitor organ function, track disease progression, and adjust treatment as needed.
Sickle Cell Disease treatment in Dubai
Effective sickle cell disease management focuses on preventing pain crises, minimizing complications, and improving quality of life.
Key treatment approaches
1. Hydroxyurea therapy:
Hydroxyurea works by boosting fetal hemoglobin (HbF) levels, which helps prevent red blood cells from becoming stiff and abnormally shaped. It is one of the most effective long-term treatment options for decreasing pain episodes and the need for hospitalizations.
2. Pain management protocols:
Pain crises are usually managed with a structured, stepwise approach:
- Mild pain: Often managed with hydration and over-the-counter medications such as NSAIDs.
- Moderate to severe pain: Stronger medications may be needed, including opioids, under medical supervision.
- Supportive care: Oxygen therapy and intravenous fluids when necessary.
3. Blood transfusion therapy:
These may be used regularly or in specific situations to:
- Lower the risk of stroke in high-risk individuals
- Treat severe anemia.
- Reduce complications in chronic cases.
4 Bone marrow (stem cell) transplant:
In selected cases, particularly in children or those with severe disease, a bone marrow transplant may offer a long-term solution.
This procedure involves replacing diseased bone marrow with healthy donor cells, enabling the body to produce normal red blood cells. Careful evaluation is required to determine if a patient is a suitable candidate.
Managing these treatments requires the expertise of an experienced hematologist in Bahrain, ensuring each patient receives a personalized plan along with close monitoring.
Pediatric Sickle Cell care: A foundation for the future
Children with sickle cell disease benefit greatly from early and proactive care, which helps prevent long-term complications and supports healthy development.
At King’s College Hospital London – Dubai, Bahrain Clinic, pediatric care includes:
- Early initiation of prophylactic antibiotics and vaccinations
- Growth and neurodevelopment monitoring
- Parental education for crisis prevention
- Rapid-response protocols for fever or pain episodes
- Regular screening for stroke risk in children
Early intervention plays a major role in improving life expectancy and reducing complications later in life.
Why choose King’s College Hospital Bahrain for Sickle Cell disease treatment in Bahrain?
Pediatric sickle cell disease care in Bahrain now meets the standards families once had to travel internationally to access. King’s College Hospital Bahrain bridges the gap between Dubai and London-level surgical expertise and regional accessibility in the GCC.
- UK-linked expertise: Care based on King’s London standards adapted for Bahrain
- Multidisciplinary approach: Collaboration between hematology, neurology, and pain specialists.
- Access to advanced treatments: Including hydroxyurea, transfusions, and infection prevention strategies.
- Complex case experience: Experience in managing severe disease and related complications.
- Family-centered approach: Clear guidance, ongoing support, and long-term follow-up.
If your child has been diagnosed with sickle cell disease or is showing signs such as repeated pain episodes, ongoing fatigue, or frequent infections, seeking early care from a specialist is crucial.
Book a consultation today.
FAQs
The most effective long-term treatment includes hydroxyurea therapy, pain management, preventive care, and blood transfusions when necessary, guided by a specialist hematologist.
At present, there is no universal cure, but treatments can significantly reduce symptoms and complications. In select cases, bone marrow transplantation may offer a potential cure.
You should consult a hematologist immediately after diagnosis or if you experience frequent pain crises, anemia, or complications such as infections or fatigue.
Yes, without early treatment it can lead to infections, stroke, and growth delays. However, early pediatric care dramatically improves outcomes.
Sickle cell anemia treatment usually includes medications to manage pain and prevent complications, routine care to reduce infection risk, and treatments such as blood transfusions, all tailored for long-term management of sickle cell disease.